Literature DB >> 19125842

Italian consensus conference on epilepsy and pregnancy, labor and puerperium.

Umberto Aguglia1, Giancarlo Barboni, Dina Battino, Giovan Battista Cavazzuti, Angela Citernesi, Roberto Corosu, Francesco Maria Guzzetta, Paola Iannetti, Daniela Mamoli, Alfredo Patella, Lorenzo Pavone, Emilio Perucca, Francesco Primiero, Dario Pruna, Salvatore Savasta, Luigi Maria Specchio, Alberto Verrotti.   

Abstract

To facilitate an integrated and rational approach to the care of women with epilepsy of childbearing potential, a group of experts appointed by Italian scientific societies in the fields of epileptology, neonatology, pediatrics, neuropediatrics, child neuropsychiatry, obstetrics, and gynecology held a joint meeting in Santa Trada di Cannitello, Reggio Calabria, Italy, on October 15-16, 2004, with the aim of reaching consensus on the optimal management of these women. An ad hoc system for the classification of available published evidence and the opinions of experts was developed and used to grade recommendations on different aspects related to counseling, diagnostic, and treatment issues. The present document summarizes available evidence on the reciprocal interactions between epilepsy, antiepileptic drugs, fertility, contraception, pregnancy, delivery, breastfeeding, and the offspring. Recommendations are made concerning the information and counseling that should be provided to women with epilepsy with respect to issues related to contraception, conception, pregnancy, labour, and puerperium. More detailed recommendations on the same issues are provided to physicians and other healthcare professionals involved in the care of these women, with special reference to choice of effective contraception, optimization of antiepileptic drug therapy, use of prenatal diagnostic tests and other monitoring procedures, and appropriate management practices in relation to childbirth, puerperium, and the care of the child.

Entities:  

Mesh:

Year:  2009        PMID: 19125842     DOI: 10.1111/j.1528-1167.2008.01964.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide.

Authors:  Bruna Nucera; Francesco Brigo; Eugen Trinka; Gudrun Kalss
Journal:  Ther Adv Neurol Disord       Date:  2022-06-11       Impact factor: 6.430

2.  The 50th anniversary of the Italian League against epilepsy (Lega Italiana Contro l'Epilessia).

Authors:  Laura Tassi; Nicola Specchio; Oriano Mecarelli; Paolo Tinuper; Federico Vigevano; Emilio Perucca
Journal:  Epilepsy Behav Rep       Date:  2022-05-20

Review 3.  An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes.

Authors:  Elizabeth E Gerard; Kimford J Meador
Journal:  J Pediatr Genet       Date:  2015-06

4.  Antiepileptic drug interactions - principles and clinical implications.

Authors:  Svein I Johannessen; Cecilie Johannessen Landmark
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

5.  Predicting seizures in pregnant women with epilepsy: Development and external validation of a prognostic model.

Authors:  John Allotey; Borja M Fernandez-Felix; Javier Zamora; Ngawai Moss; Manny Bagary; Andrew Kelso; Rehan Khan; Joris A M van der Post; Ben W Mol; Alexander M Pirie; Dougall McCorry; Khalid S Khan; Shakila Thangaratinam
Journal:  PLoS Med       Date:  2019-05-13       Impact factor: 11.069

6.  Maternal complications in pregnancy and childbirth for women with epilepsy: Time trends in a nationwide cohort.

Authors:  Kim Christian Danielsson; Nils Erik Gilhus; Ingrid Borthen; Rolv Terje Lie; Nils-Halvdan Morken
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

7.  The Rate of and Factors Associated with Delivery by Caesarean Section among Women with Epilepsy: Time Trend in a Single-Centre Cohort in Mazovia, Poland.

Authors:  Beata Majkowska-Zwolińska; Joanna Jędrzejczak
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.